For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Desmopressin acetate - Nocturnal polyuria (women)
PAD Profile : Desmopressin acetate - Nocturnal polyuria (women)
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
No drugs returned.
Other Indications
Additional Documents
Committee Recommendations
The Surrey and North West Sussex Area Prescribing Committee (APC) recommends desmopressin (Noqdirna) as a treatment option for idiopathic noturnal polyuria.
Desmopressin (Noqdirna) is a licensed product and should be prescibed as an alternative to other, off label desmopressin preparations.
Desmopressin (Noqdirna) will be assigned a BLUE (no information sheet) traffic light status and specialists in secondary care will be required to prescribe at least 1 month of desmopressin prior to requesting transfer of care with the patients primary care provider.
The attached nocturia treatment pathway has been developed in conjunction with colleagues at Ashford & St Peters Hospitals NHS Foundation Trust and is expected to assist primary care prescribers in the management of patients with nocturia. See below for further information